Top 10 Most Popular Chinese Human Rabies Vaccine Adjuvant Brands

June 16, 2024

The human rabies vaccine adjuvant market is experiencing growth due to increasing awareness about Rabies Prevention. The demand for adjuvants that enhance the immune response to the vaccine is driving market growth. Key players are focusing on research and development to improve vaccine efficacy and safety. The market is expected to expand further as governments invest in rabies prevention programs.

Changsheng Bio
Kangtai Bio
Zhejiang Tianyuan Bio-Pharmaceutical
Sinovac
Hualan Bio
Changchun Zhuoyi Biological Co., Ltd
Walvax Biotech

Changsheng Bio

Establishment time : Changsheng Bio-technology Co., Ltd. was founded in 1992.

website : www.changsheng.com

Main Product : Changsheng Bio's main products include vaccines, blood products, and diagnostic reagents.

Company Profile

Despite its success, Changsheng Bio has faced challenges related to quality control issues in the past.

Kangtai Bio

Establishment time : 2003

website : www.kangtaibio.com

Main Product : In vitro diagnostic reagents, medical devices

Company Profile

Kangtai Bio is a leading manufacturer of in vitro diagnostic reagents and medical devices. Founded in 2003, the company has grown to become a key player in the healthcare industry, serving markets in China, Southeast Asia, Middle East, and Africa. With a focus on innovation and quality, Kangtai Bio continues to expand its product portfolio and reach new customers worldwide.

Zhejiang Tianyuan Bio-Pharmaceutical

Establishment time : 1994

website : www.tyb.com

Main Product : Human insulin, insulin API, insulin analogs

Company Profile

Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a leading manufacturer of insulin products in China, with a focus on providing high-quality and affordable diabetes treatments. Founded in 1994, the company has grown to become a key player in the pharmaceutical industry, serving markets around the world with its innovative products and commitment to improving patient health.

Sinovac

Establishment time : Sinovac Biotech Ltd. is a leading biopharmaceutical company based in China.

website :

Main Product : Sinovac is known for its expertise in developing and producing vaccines for a wide range of infectious diseases.

Company Profile

Sinovac's mission is to protect and improve the health of people worldwide through the development of safe and effective vaccines.

Hualan Bio

Establishment time : Hualan Bio is a biopharmaceutical company founded in 1992.

website :

Main Product : With over 3,000 employees, Hualan Bio is a major player in the Chinese biopharmaceutical industry.

Company Profile

For more information, visit the company's website at www.hualanbio.com.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Walvax Biotech

Establishment time : Founded in 2000, Walvax Biotech is a leading vaccine manufacturer based in China.

website :

Main Product : With a medium-sized workforce, Walvax Biotech has established itself as a key player in the Chinese market.

Company Profile

With a reputation for excellence and innovation, Walvax Biotech continues to be a trusted name in the healthcare industry.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326